Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Humphreys, US

Alan Humphreys, Somerville, MA US

Patent application numberDescriptionPublished
20090142594EROSION RESISTANT SURFACE AND METHOD OF MAKING EROSION RESISTANT SURFACES - An erosion resistant surface using a dense array of elastic whiskers to slow the velocity of erosive particles before impacting with the surface. A carbon nanotube forest is grown on the surface to provide the erosion resistance. In the alternative, a carbon nanotube forest is grown on a flexible substrate that is bonded to the surface.06-04-2009

Bradley T. Humphreys, Lakewood, OH US

Patent application numberDescriptionPublished
20090240117DATA ACQUISITION FOR MODULAR BIOMETRIC MONITORING SYSTEM - A modular system for acquiring biometric data includes a plurality of data acquisition modules configured to sample biometric data from at least one respective input channel at a data acquisition rate. A representation of the sampled biometric data is stored in memory of each of the plurality of data acquisition modules. A central control system is in communication with each of the plurality of data acquisition modules through a bus. The central control system is configured to collect data asynchronously, via the bus, from the memory of the plurality of data acquisition modules according to a relative fullness of the memory of the plurality of data acquisition modules.09-24-2009

Don Humphreys, Pittsburgh, PA US

Patent application numberDescriptionPublished
20120064388Metal-Free Aqueous Electrolyte Energy Storage Device - An electrochemical device including a housing and a stack of electrochemical cells in the housing. Each electrochemical cell includes an anode electrode, a cathode electrode, a separator located between the anode electrode and the cathode electrode and an electrolyte. The electrochemical device also includes a current collector located between adjacent electrochemical cells, an anode bus operatively connected to the anodes of the electrochemical cells in the stack and a cathode bus operatively connected to the cathodes of the electrochemical cells in the stack. The housing, the anode electrode, the cathode electrode, the separator, the anode bus and the cathode bus are non-metallic.03-15-2012

Geoffrey Humphreys, Baton Rouge, LA US

Patent application numberDescriptionPublished
20120039520Digital Radiography Place Identification System - Systems, devices, and methods for facilitating the automatic identification, sorting, and positioning of radiographic images. According to one embodiment of the subject invention, phosphorous plates for intra-oral imaging are encoded for automated image set identification, location, and orientation. In certain embodiments, a processing system is able to process encoded identifiers on the phosphorous plates with digitized images depicted on the phosphorous plates to automatically identify, sort, and rotate the digitized images into proper orientations for user viewing.02-16-2012

Geraldine Ibanez Humphreys, Petrolia, PA US

Patent application numberDescriptionPublished
20100189674Petrolatum Having Silicone-Like Properties - Novel petrolatums having silicone-like properties are disclosed. Silicone-free compositions containing the novel petrolatums also are disclosed.07-29-2010

Ian R. Humphreys, Del Mar, CA US

Patent application numberDescriptionPublished
20090311280NOVEL TNF RECEPTOR REGULATORY DOMAIN - Herpesvirus entry mediator (HVEM) is a member of the tumor necrosis factor receptor superfamily (TNFRSF) and acts as a molecular switch that modulates T cell activation by propagating positive signals from the TNF related ligand, LIGHT (p30, TNFSF14), or inhibitory signals through the immunoglobulin superfamily member, B and T lymphocyte attenuator (BTLA). A novel binding site for BTLA is disclosed, located in cysteine-rich domain-1 of HVEM. BTLA binding site on HVEM overlaps with the binding site for the Herpes Simplex virus-1 envelope glycoprotein D (gD), but is distinct from where LIGHT binds, yet gD inhibits the binding of both ligands. A BTLA activating protein present in human cytomegalovirus is identified as UL144. UL144 binds BTLA, but not LIGHT, and inhibits T cell proliferation.12-17-2009

John Humphreys, Mission Hills, KS US

Patent application numberDescriptionPublished
20090173031Stepped tile shingle - A shingle includes a body having an upper end, a lower end, a top surface, a bottom surface, a first side and a second side. The body has a width defined as the distance between the two opposing sides, a length defined by the distance between the upper end and the lower end. In a preferred embodiment, the shingle also includes a side wall that extends downward from the body adjacent one of the sides and extends the length of the shingle. The side wall preferably includes an angular projection disposed toward the upper end.07-09-2009

John Humphreys, Lenexa, KS US

Patent application numberDescriptionPublished
20090260309Synthetic roofing shingles - Disclosed is a coated synthetic shingle that exhibits increased resistance to ultra-violet radiation. The shingle is useable for roofing applications and includes a substrate having a substrate surface and a base coat that is applied to the substrate surface. The base coat preferably includes a first fluoropolymer component. The shingle can also include a top coat that is applied to the base coat. The top coat preferably includes a clear acrylic coating. A method for manufacturing the shingle is also disclosed.10-22-2009

Johnny Humphreys, Veradale, WA US

Patent application numberDescriptionPublished
20090014486Golf bag motorcycle transport system - A golf bag system is provided for transporting a golf bag on a motorcycle, the system including an apparatus and method wherein a first bag side and a second bag side are utilized such that the first bag side is mounted on an opposing side of the motorcycle to the second bag side. When the golf bag is to be utilized to play golf, the golf bag system provides for the operative attachment of the first bag side to the second bag side to become an integral or combined golf bag. The respective golf bag sides include a framework and are mounted rearward of the first rider position on the motorcycle, and may be supported in part by foot pegs that would otherwise be utilized by a passenger on the motorcycle. There are cross supports and other means to attach the respective bag sides to and around the motorcycle and/or to each other for a balanced and comfortable operation of the motorcycle during the transport of the golf bag system.01-15-2009
20100045789APPARATUS, METHOD AND ARTICLE TO PERFORM ASSAYS USING ASSAY STRIPS - An assay system includes an optical imager to acquire high resolution images of assay strips (e.g., lateral flow immunochromatographic test strips) and performs image processing to identify individual assay strips and determine results for each assay strip, by quantifies the presence or absence of test signal line(s) and control signal line(s). Assay strips may be in a holder or carrier contained in a specimen container also holding a specimen. The assay system automatically logs all results and data to a database that stores a high resolution image of the original immunochromatographic assay, the values of test line(s) and control line(s), and the test result. A user interface directs an end user through operation.02-25-2010

Ken Humphreys, Eugene, OR US

Patent application numberDescriptionPublished
20120008815LOUDSPEAKER THAT IS AXIALLY STABILIZED OUT OF THE DIAPHRAGM SUSPENSION PLANE - An improved mid to high-frequency loudspeaker of the type having a central dome diaphragm having an outer periphery, and in one embodiment an outer ring-radiator diaphragm portion defining an inner periphery and an outer periphery, the ring-radiator diaphragm being attached at its inner periphery to an armature voice coil assembly and at its outer periphery to a diaphragm chassis in a first plane. The central diaphragm portion is attached at its outer periphery to either the inner periphery of the outer ring-radiator diaphragm or the voice coil armature, and the improvement comprises axially-located stabilizing means attached to the central diaphragm portion, or alternatively a central stabilizing framework, in a second plane parallel to the first plane and that is of sufficient distance from the first plane to provide leverage sufficient to stabilize the diaphragm to minimize rocking, allow improved alignment of the voice coil allowing tighter tolerances between the voice coil and magnet assembly, thus improving performance and minimizing distortion.01-12-2012

Kevin R. Humphreys, Memphis, TN US

Patent application numberDescriptionPublished
20120095513RETAINING MECHANISM - A retaining mechanism for use in affixing a stratum to bone is disclosed. The retaining mechanism comprises a stratum, a shoulder element and a retaining element. The stratum comprises a first surface, a second surface, and at least one hole extending between the first surface and the second surface, wherein the second surface is configured to engage at least a portion of the bone. The shoulder element is configured to engage the stratum and configured to at least partially overlap the at least one hole. The retaining element is configured to engage the stratum and configured to at least partially overlap the shoulder element such that the shoulder element helps prevent inadvertent backing out of a fastener after the fastener has been fully inserted into the at least one hole.04-19-2012

Matthew Humphreys, San Jose, CA US

Patent application numberDescriptionPublished
20110055844HIGH DENSITY MULTI NODE COMPUTER WITH INTEGRATED SHARED RESOURCES - A multi-node computer system, comprising: a plurality of nodes, a system control unit and a carrier board. Each node of the plurality of nodes comprises a processor and a memory. The system control unit is responsible for: power management, cooling, workload provisioning, native storage servicing, and I/O. The carrier board comprises a system fabric and a plurality of electrical connections. The electrical connections provide the plurality of nodes with power, management controls, system connectivity between the system control unit and the plurality of nodes, and an external network connection to a user infrastructure. The system control unit and the carrier board provide integrated, shared resources for the plurality of nodes. The multi-node computer system is provided in a single enclosure.03-03-2011

Mitchell R. Humphreys, Cave Creek, AZ US

Patent application numberDescriptionPublished
20090281507Hemostatic Devices and Methods For Use Thereof - Materials and Methods for reducing or preventing bleeding and associated side effects during and after percutaneous medical procedures.11-12-2009

Mitchell R. Humphreys, Scottsdale, AZ US

Patent application numberDescriptionPublished
20080243091Process and System For Systematic Oxygenation and Renal Preservation During Retrograde Perfusion of the Ischemic Kidney - A delivery system to provide end organ oxygenation and even systematic oxygenation in the face of ischemic result. The deliver system including a retrograde oxygenation and perfusion stent. The stent employing at least two and possibly more channels to allow flow of the perfusate from the device to the renal pelvis then to a back out to a collection apparatus. The stent may include various vital sign monitors, such as a renal pressure monitor, temperature monitor, and even an oxygenation monitor. The stent may include an anchoring device to allow the stent to be anchored into the renal pelvis in a temporary way during the retrograde oxygenation process.10-02-2008

Paul Humphreys, Los Angeles, CA US

Patent application numberDescriptionPublished
20100147133ADAPTABLE PIPE INSTRUMENT & METHODS OF USE THEREOF - Embodiments of the invention are directed to an adaptable panpipe instrument and methods of use thereof. In one embodiment, the adaptable panpipe instrument includes a collar brace with a plurality of openings. The plurality of openings may be of the same size or varying sizes and are capable of receiving pipe components of a panpipe instrument. When a plurality of pipe components are positioned within the collar brace in a given configuration, it may be secured to the brace by friction-fit, a webbing, and/or one or more fasteners. One or more of the plurality of pipe components may be adjusted relative to the other pipe components by sliding them up or down which may also adjust the musical scale of that pipe.06-17-2010
20110239842ADAPTABLE PIPE INSTRUMENT & METHODS OF USE THEREOF - Embodiments of the invention are directed to an adaptable panpipe instrument and methods of use thereof. In one embodiment, the adaptable panpipe instrument includes a collar brace with a plurality of openings. The plurality of openings may be of the same size or varying sizes and are capable of receiving pipe components of a panpipe instrument. When a plurality of pipe components are positioned within the collar brace in a given configuration, it may be secured to the brace by friction-fit, a webbing, and/or one or more fasteners. One or more of the plurality of pipe components may be adjusted relative to the other pipe components by sliding them up or down which may also adjust the musical scale of that pipe.10-06-2011

Robert Humphreys, Acton, MA US

Patent application numberDescriptionPublished
20090060936Ii-Key/Her-2/neu hybrid cancer vaccine - Provided are methods and compositions for treating cancer in humans, the cancer being characterized by expression of Her-2/neu. The methods involve vaccinating a patient with an Ii-Key/MHC class II hybrid construct and thereby stimulating an immune response to the native Her-2/neu protein. The construct may be in the form of an Ii-Key hybrid peptide or a nucleic acid encoding an Ii-Key hybrid peptide. Methods are described wherein the cancer being treated is breast cancer. Also claimed is a pharmaceutical composition comprising an Ii-Key/MHC class II hybrid construct with and without an adjuvant. The adjuvant can include GM-CSF. The Ii-Key hybrid construct includes the LRMK (SEQ ID NO: 2) residues of Ii-Key protein and an MHC Class II epitope of a protein or portion thereof which is used in the vaccine or a DNA encoding the same hybrid peptide.03-05-2009
20100150953Ii-KEY/HER-2/NEU HYBRID CANCER VACCINE - Provided are methods and compositions for treating cancer in humans, the cancer being characterized by expression of Her-2/neu. The methods involve vaccinating a patient with an Ii-Key/MHC class II hybrid construct and thereby stimulating an immune response to the native Her-2/neu protein. The construct may be in the form of an Ii-Key hybrid peptide or a nucleic acid encoding an Ii-Key hybrid peptide. Methods are described wherein the cancer being treated is breast cancer. Also claimed is a pharmaceutical composition comprising an Ii-Key/MHC class II hybrid construct with and without an adjuvant. The adjuvant can include GM-CSF. The Ii-Key hybrid construct includes the LRMK residues of Ii-Key protein and an MHC Class II epitope of a protein or portion thereof which is used in the vaccine or a DNA encoding the same hybrid peptide.06-17-2010
20100255019Ii-KEY/HER-2/NEU HYBRID CANCER VACCINE - Provided are methods and compositions for treating cancer in humans, the cancer being characterized by expression of Her-2/neu. The methods involve vaccinating a patient with an Ii-Key/MHC class II hybrid construct and thereby stimulating an immune response to the native Her-2/neu protein. The construct may be in the form of an Ii-Key hybrid peptide or a nucleic acid encoding an Ii-Key hybrid peptide. Methods are described wherein the cancer being treated is breast cancer. Also claimed is a pharmaceutical composition comprising an Ii-Key/MHC class II hybrid construct with and without an adjuvant. The adjuvant can include GM-CSF. The Ii-Key hybrid construct includes the LRMK [SEQ ID NO.: 2] residues of Ii-Key protein and an MHC Class II epitope of a protein or portion thereof which is used in the vaccine or a DNA encoding the same hybrid peptide.10-07-2010
20100291145Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES - Disclosed is a nucleic acid molecule comprising a first expressible sequence encoding a protein of interest or polypeptide of interest which contains an MHC Class II-presented epitope, or said encoded protein or peptide. In addition, the nucleic acid molecule comprises a second expressible nucleic acid sequence encoding an antigen presentation enhancing hybrid polypeptide, or said encoded protein or peptide. The antigen presentation enhancing hybrid polypeptide includes the following elements: i) an N-terminal element consisting essentially of 4-16 residues of the mammalian Ii-Key peptide LRMKLPKPPKPVSKMR (SEQ ID NO: 1) and non-N-terminal deletion modifications thereof that retain antigen presentation enhancing activity; ii) a C-terminal element comprising an MHC Class II-presented epitope in the form of a polypeptide or peptidomimetic structure which binds to the antigenic peptide binding site of an MHC class II molecule, the MHC Class II-presented epitope being contained in the protein of interest of step a); and iii) an intervening peptidyl structure linking the N-terminal and C-terminal elements of the hybrid, the peptidyl structure having a length of about 20 amino acids or less.11-18-2010
20100310591Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA - The present invention provides an MHC class II antigen presentation enhancing hybrid polypeptide. The hybrid has an N-terminus comprising the mammalian Ii-key peptide LRMKLPKPPKPVSKMR (SEQ ID NO: 1) and modifications thereof which retain antigen presentation enhancing activity, a C-terminus comprising an antigenic epitope in the form of a polypeptide or peptidomimetic structure which binds to the antigenic peptide binding site of an MHC class II molecule, and an intervening chemical structure covalently linking the N-terminal and C-terminal components. In a particular embodiment, the hybrid peptides of the present invention comprise influenza MHC class II epitopes identified herein as being effective in generating an immune response and provide immunity to the individual.12-09-2010

Patent applications by Robert Humphreys, Acton, MA US

Robert E. Humphreys, Acton, MA US

Patent application numberDescriptionPublished
20080305122Ii-Key/antigenic epitope hybrid peptide vaccines - Disclosed is a nucleic acid molecule comprising a first expressible sequence encoding a protein of interest or polypeptide of interest which contains an MHC Class II-presented epitope. In addition, the nucleic acid molecule comprises a second expressible nucleic acid sequence encoding an antigen presentation enhancing hybrid polypeptide. The antigen presentation enhancing hybrid polypeptide includes the following elements: i) an N-terminal element consisting essentially of 4-16 residues of the mammalian Ii-Key peptide LRMKLPKPPKPVSKMR (SEQ ID NO: 1) and non-N-terminal deletion modifications thereof that retain antigen presentation enhancing activity; ii) a C-terminal element comprising an MHC Class II-presented epitope in the form of a polypeptide or peptidomimetic structure which binds to the antigenic peptide binding site of an MHC class II molecule, the MHC Class II-presented epitope being contained in the protein of interest of step a); and iii) an intervening peptidyl structure linking the N-terminal and C-terminal elements of the hybrid, the peptidyl structure having a length of about 20 amino acids or less.12-11-2008

Scott Robert Humphreys, Greensboro, NC US

Patent application numberDescriptionPublished
20110038488WIRELESS MUSICAL INSTRUMENT NETWORK AND WIRELESS LINK MODULES - A wireless musical instrument network (02-17-2011

S. Craig Humphreys, Chattanooga, TN US

Patent application numberDescriptionPublished
20110247634Unitary Structured Multi-Tier Drape - A drape having a pair of elongated sheets connected at distal ends to define a skirt, with opposing side walls in a first portion of the elongated sheets having a first width and in a second portion having a different width so the drape has a stair-step structure, with a paper and plastic laminated first and second tier panels attached to the elongated sheets in spaced-relation and a central panel attached therebetween, for covering a tiered surgical operating table.10-13-2011

Steven C. Humphreys, Chattanooga, TN US

Patent application numberDescriptionPublished
20090182429Total joint Replacement - An artificial vertebral joint for interposition between a superior vertebra and an inferior vertebra comprises a pair of bilateral joint subcomponents. Each joint subcomponent includes a superior component including a superior vertebra engaging surface and an inferior component including an inferior vertebra engaging surface. Each joint subcomponent further includes a spacer extending between the superior component and the inferior component. The spacer includes a first modulus of elasticity and a second modulus of elasticity. The first modulus transitions to the second modulus with a gradient change.07-16-2009
20090254183Spinal Arthroplasty Device and Method - An artificial spinal joint and methods for replacing at least a portion of a natural intervertebral disc are provided. In some embodiments, at least portions of facet joints are replaced along with the intervertebral disc.10-08-2009
20090254184Spinal Arthroplasty Device and Method - An artificial spinal joint and methods for replacing at least a portion of a natural intervertebral disc are provided. In some embodiments, at least portions of facet joints are replaced along with the intervertebral disc.10-08-2009
20090259255Spinal Arthroplasty Device and Method - An artificial spinal joint and methods for replacing at least a portion of a natural intervertebral disc are provided. In some embodiments, at least portions of facet joints are replaced along with the intervertebral disc.10-15-2009
20100298938Spinal Device and Method - An artificial spinal joint, for creating at least a portion of a coupling between a superior vertebra and an inferior vertebra, comprises an anterior joint replacement component sized to extend into an intervertebral disc space between the superior and inferior vertebrae. The anterior joint replacement component includes a left anterior member separated and spaced apart from a right anterior member. The artificial spinal joint further comprises a bridge component coupled at a first end to the anterior joint replacement and sized to extend posteriorly outside the intervertebral disc space. The bridge component includes a left bridge member separated and spaced apart from a right bridge member. The artificial spinal joint further comprises a posterior joint replacement component coupled to a second end of the bridge component. The posterior joint replacement component includes a left posterior member separated and spaced apart from a right posterior member.11-25-2010

Patent applications by Steven C. Humphreys, Chattanooga, TN US

Steven Craig Humphreys, Chattanooga, TN US

Patent application numberDescriptionPublished
20080300685Posterior Total Joint Replacement - A prosthetic system for implantation between upper and lower vertebrae comprises an upper joint component. The upper joint component comprises an upper contact surface and an upper articulation surface. The system further includes a lower joint component. The lower joint component comprises a lower contact surface and a lower articulation surface configured to movably engage the upper articulation surface to form an articulating joint. The articulating joint is adapted for implantation within a disc space between the upper and lower vertebrae, allowing the upper and lower vertebrae to move relative to one another. The system further includes a bridge component extending posteriorly from one of either the upper or lower joint components and from the disc space. The bridge component has a distal end opposite the one of the either upper or lower joint components. The distal end of the bridge component comprises a connection component adapted to receive a fastener.12-04-2008

Sue Humphreys, Rotonda West, FL US

Patent application numberDescriptionPublished
20110071842JUDICIAL CASE MANAGEMENT COMPUTER SYSTEM AND METHOD FOR PROVIDING THE SAME - A judicial case management computer system and a method for providing the same are provided. The judicial case management computer system includes storage. A set of differentiated case management (“DCM”) tracks are stored in the storage. Each of the DCM tracks represents a case type. The DCM tracks include a set of triggering events and a set of DCM elements consequential to the triggering events. A set of business rules corresponding with each of the DCM elements is provided. The set of business rules specify at least one condition for the DCM element. Computer-executable instructions are stored in the storage. The computer-executable instructions implement software when executed on the computer system for receiving a notification of the occurrence of one of the triggering events for a case, identifying the DCM elements corresponding to the one triggering event, and processing the identified DCM elements in accordance with the set of business rules for the DCM elements.03-24-2011

Thomas R. Humphreys, St. Petersburg, FL US

Patent application numberDescriptionPublished
20100044403GARMENT HANGER APPARATUS - A garment hanger apparatus includes an elongated barrel having opposed ends and a plurality of longitudinally spaced circumferential groves formed completely around the circumference of the exterior surface of the barrel. A frame having a pair of ends, one each of the pair of ends disposed in one end of the opposed ends of the elongated barrel, the frame further having an open end loop portion disposed transverse to the elongated barrel and with the open end facing the barrel.02-25-2010

Todd E. Humphreys, Half Moon Bay, CA US

Patent application numberDescriptionPublished
20110163913Practical Method for Upgrading Existing GNSS User Equipment with Tightly Integrated Nav-Com Capability - A practical method for adding significant new high-performance, tightly integrated Nav-Com capability to any Global Navigation Satellite System (GNSS) user equipment, such as GPS receivers, requires no hardware modifications to the existing user equipment. In one example, the iGPS concept is applied to a Defense Advanced GPS Receiver (DAGR) and combines Low Earth Orbiting (LEO) satellites, such as Iridium, with GPS or other GNSS systems to significantly improve the accuracy, integrity, and availability of Position, Navigation, and Timing (PNT)—in some cases by three orders of magnitude, to enable high precision GNSS carrier phase observable to be more readily exploited to improve PNT availability—even under interference conditions or occluded environments, and to enable new communication enhancements made available by the synthesis of precisely coupled navigation and communication modes. To achieve time synchronization stability to the required sub-20 ps level between the existing DAGR and a plug-in iGPS enhancement module, a special-purpose wideband reference signal is generated by the iGPS module and coupled to the DAGR via the existing antenna port, so that no hardware modification of the DAGR is required.07-07-2011

Todd E. Humphreys, Austin, TX US

Patent application numberDescriptionPublished
20110068973Assimilating GNSS Signals to Improve Accuracy, Robustness, and Resistance to Signal Interference - A method for upgrading GNSS equipment to improve position, velocity and time (PVT) accuracy, increase PVT robustness in weak-signal or jammed environments and protect against counterfeit GNSS signals (spoofing). A GNSS Assimilator couples to an RF input of existing GNSS equipment, e.g., a GPS receiver, and extracts navigation and timing information from available RF signals, including non-GNSS signals, or direct baseband aiding, e.g., from an inertial navigation system, frequency reference, or GNSS user. The Assimilator fuses the diverse navigation and timing information to embed a PVT solution in synthesized GNSS signals provided to a GNSS receiver RF input. The code and carrier phases of the synthesized GNSS signals are aligned with those of actual GNSS signals to appear the same at the target receiver input. The Assimilator protects against spoofing by continuously scanning incoming GNSS signals for signs of spoofing, and mitigating spoofing effects in the synthesized GNSS signals.03-24-2011
20110102259Augmenting GNSS User Equipment to Improve Resistance to Spoofing - A method of countering GNSS signal spoofing includes monitoring a plurality of GNSS signals received from a plurality of GNSS signal sources and comparing broadcast data to identify outlying data, which is excluded from generation of a navigation solution defined by the plurality of GNSS signals. The outlying data can be a vestigial signal from a code or carrier Doppler shift frequency. The method includes triggering a spoofing indicator upon identification of the outlying data or other phenomenon. The phenomenon can include a shift in a phase of a measured GNSS navigation data bit sequence or a profile phenomenon of a correlation function resulting from correlation of the incoming GNSS signals with a local signal replica. The profile phenomenon can be the presence of multiple sustained correlation peaks. A nullifying signal can be generated and superimposed over a compromised signal.05-05-2011
20110109506Simulating Phase-Coherent GNSS Signals - A method and apparatus for simulating radio-frequency Global Navigation Satellite System (GNSS) signals that are carrier-phase and code-phase aligned with ambient GNSS signals at a user-specified location in the vicinity of the simulator. Such phase alignment allows the synthesized signals to be made to appear substantially the same as the authentic signals to a target receiver, allowing the target receiver to transition seamlessly between authentic and simulated signals. The method is embodied in a device, a phase-coherent GNSS signal simulator, which can be implemented on a digital signal processor for embedded applications.05-12-2011

Tom Humphreys, Honolulu, HI US

Patent application numberDescriptionPublished
20080213318Malaria MSP-1 C-terminal enhanced subunit vaccine - A vaccine or immunogenic composition is described that contains recombinantly produced, secreted, forms of malaria MSP-1 C-terminal subunit proteins from any of the 09-04-2008
20120065371Recombinant proteins from filoviruses and their use - Filovirus subunit protein immunogens are produced using a recombinant expression system and combined with one or more adjuvants in immunogenic formulations. The subunit proteins include GP95, GP-FL, VP40, VP24, and NP derived from Ebola Virus and Marburg Virus. Adjuvants include saponins, emulsions, alum, and dipeptidyl peptidase inhibitors. The disclosed immunogenic formulations are effective in inducing strong antibody responses directed against individual Filovirus proteins and intact Filovirus particles as well as stimulating cell-mediated immune responses to the Filoviruses.03-15-2012

Patent applications by Tom Humphreys, Honolulu, HI US